This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Designing an IHC experiment for Ataxin-3? The guide has the expected staining pattern, antigen retrieval and fixation, antibodies backed by real IHC images, the tissue controls to run alongside, and protocols taken from published papers.
Open the ATXN3 IHC GuideFacts about Ataxin-3.
Involved in degradation of misfolded chaperone substrates through its interaction with STUB1/CHIP: recruited to monoubiquitinated STUB1/CHIP, and restricts the length of ubiquitin chain attached to STUB1/CHIP substrates and preventing further chain extension (By similarity). Interacts with key regulators of transcription and represses transcription: acts as a histone-binding protein that regulates transcription (PubMed:12297501).
| Human | |
|---|---|
| Gene Name: | ATXN3 |
| Uniprot: | P54252 |
| Entrez: | 4287 |

| Belongs to: |
|---|
| No superfamily |

AT3; ataxin 3; Ataxin3; Ataxin-3; ATX3AT3; ATXN3; EC 3.4.19.12; EC 3.4.22; JOS; Machado-Joseph disease protein 1; MJD1; MJDolivopontocerebellar ataxia3, autosomal dominant, ataxin 3); olivopontocerebellar ataxia 3; SCA3; Spinocerebellar ataxia type 3 protein
Mass (kDA):
41.25 kDA

| Human | |
|---|---|
| Location: | 14q32.12 |
| Sequence: | 14; NC_000014.9 (92058552..92106621, complement) |
Ubiquitous.
Nucleus matrix. Nucleus. Predominantly nuclear, but not exclusively, inner nuclear matrix.





PMID: 7874163 by Kawaguchi Y., et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1.
PMID: 9274833 by Goto J., et al. Machado-Joseph disease gene products carrying different carboxyl termini.